These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Lethal congenital dyserythropoietic anaemia type I in siblings presenting as pericardial effusions in the second trimester. Stone P, Zuccollo J. Fetal Diagn Ther; 1999; 14(1):11-4. PubMed ID: 10072642 [Abstract] [Full Text] [Related]
29. Unveiling the genetic landscape of suspected congenital dyserythropoietic anemia type I: A retrospective cohort study of 36 patients. Marra R, Nostroso A, Rosato BE, Esposito FM, D'Onofrio V, Iscaro A, Gambale A, Bruschi B, Coccia P, Poloni A, Unal S, Romano A, Iolascon A, Andolfo I, Russo R. Am J Hematol; 2024 Aug; 99(8):1511-1522. PubMed ID: 38666530 [Abstract] [Full Text] [Related]
35. Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS). Denecke J, Kranz C, Nimtz M, Conradt HS, Brune T, Heimpel H, Marquardt T. Glycoconj J; 2008 May; 25(4):375-82. PubMed ID: 18166993 [Abstract] [Full Text] [Related]
36. Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects. Iolascon A, D'Agostaro G, Perrotta S, Izzo P, Tavano R, Miraglia del Giudice B. Haematologica; 1996 May; 81(6):543-59. PubMed ID: 9009444 [Abstract] [Full Text] [Related]
37. Congenital dyserythropoietic anaemia (CDA) with severe gout, rare Kell phenotype and erythrocyte, granulocyte and platelet membrane reduplication: a new variant of CDA type II. Lowenthal RM, Marsden KA, Dewar CL, Thompson GR. Br J Haematol; 1980 Feb; 44(2):211-20. PubMed ID: 7378299 [Abstract] [Full Text] [Related]